total attack rate (%) |
4.25 (3.44–12.79) |
7.51 (6.22–8.58) |
10.39 (8.84–11.87) |
12.95 (10.62–14.38) |
clinical attack rate (%) |
2.56 (2.11–7.72) |
4.55 (3.79–5.27) |
6.33 (5.43–7.32) |
7.88 (6.45–8.76) |
asymptomatic attack rate (%) |
1.66 (1.33–5.07) |
2.96 (2.43–3.33) |
4.03 (3.42–4.61) |
5.07 (4.14–5.54) |
case fatality rate (%) |
1.47 (1.07–2.24) |
1.43 (1.09–1.71) |
1.39 (1.15–1.66) |
1.49 (1.12–1.79) |
infection fatality rate (%) |
0.90 (0.65–1.38) |
0.88 (0.66–1.04) |
0.84 (0.70–1.01) |
0.90 (0.68–1.08) |
number of shutdown days (from 8 Sep 2020 to 7 Jan 2022) |
255 (212–297) |
216 (187–257) |
213 (171–253) |
194 (168–214) |
total cases (clinical and asymptomatic) per 100 000 |
4256 (3444–12 799) |
7517 (6227–8593) |
10 396 (8851–11 877) |
12 961 (10 635–14 391) |
total clinical cases per 100 000 |
2565 (2110–7727) |
4554 (3795–5277) |
6338 (5432–7326) |
7887 (6458–8772) |
total asymptomatic cases per 100 000 |
1662 (1334–5072) |
2965 (2433–3331) |
4037 (3419–4610) |
5073 (4443–5545) |
total hospitalized cases (acute and ICU) per 100 000 |
266 (217–787) |
470 (388–540) |
645 (42–762) |
782 (631–904) |
total acute hospitalized cases per 100 000 |
198 (165–577) |
350 (279–410) |
478 (94–563) |
582 (465–681) |
total cases admitted into the ICU per 100 000 |
68 (48–209) |
119 (91–140) |
159 (29–197) |
197 (155–230) |
total deaths per 100 000 |
36 (26–173) |
65 (47–82) |
88 (70–115) |
116 (82–146) |
proportion of infections acquired at school (%) |
5.78 (4.35–7.55) |
6.31 (5.25–7.52) |
6.76 (5.66–7.78) |
7.03 (6.22–8.18) |
proportion of infections acquired at work (%) |
11.06 (9.77–12.22) |
11.34 (10.62–12.52) |
11.39 (10.55–12.48) |
11.46 (10.98–12.13) |
proportion of infections acquired in mixed-age venues (%) |
21.90 (20.47–23.75) |
22.03 (20.52–23.15) |
22.09 (21.21–23.27) |
21.85 (20.95–22.93) |
proportion of infections acquired in the household (%) |
61.20 (59.47–62.15) |
60.23 (59.59–60.95) |
59.79 (58.99–60.63) |
59.53 (58.70–59.89) |